Home  >  Products  >  KCTD13 (potassium channel tetramerisation domain containing 13) Blocking Peptide (100ug)
KCTD13 (potassium channel tetramerisation domain containing 13) Blocking Peptide (100ug)

KCTD13 (potassium channel tetramerisation domain containing 13) Blocking Peptide (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KCTD13 antibody (Catalogue #: ARP35522_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP35522
Size: 100 ug
Weight: 36kDa
Gene: 253980
Format: Lyophilized powder
Target: KCTD13 mRNA is expressed in 3T3-L1 adipocytes and THP-1 macrophages. It is suggested that this gene provides a link between cytokine activation and DNA replication in liver as well as in other tissues.